Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

1.

Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Wang K, Chen X, Zhan Y, Jiang W, Liu X, Wang X, Wu B.

Med Oncol. 2013;30(2):574. doi: 10.1007/s12032-013-0574-z. Epub 2013 Apr 13.

PMID:
23585015
[PubMed - indexed for MEDLINE]
2.

Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer.

Kahlert C, Bergmann F, Beck J, Welsch T, Mogler C, Herpel E, Dutta S, Niemietz T, Koch M, Weitz J.

BMC Cancer. 2011 Jun 27;11:275. doi: 10.1186/1471-2407-11-275.

PMID:
21708005
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Wu XR, Sha JJ, Liu DM, Chen YH, Yang GL, Zhang J, Chen YY, Bo JJ, Huang YR.

Eur J Surg Oncol. 2013 Jan;39(1):100-6. doi: 10.1016/j.ejso.2012.10.004. Epub 2012 Oct 24.

PMID:
23102595
[PubMed - indexed for MEDLINE]
4.

Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Wu XR, Chen YH, Liu DM, Sha JJ, Xuan HQ, Bo JJ, Huang YR.

Med Oncol. 2013 Mar;30(1):346. doi: 10.1007/s12032-012-0346-1. Epub 2012 Dec 22.

PMID:
23263830
[PubMed - indexed for MEDLINE]
5.

Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma.

Schäfer A, Teufel J, Ringel F, Bettstetter M, Hoepner I, Rasper M, Gempt J, Koeritzer J, Schmidt-Graf F, Meyer B, Beier CP, Schlegel J.

Neuro Oncol. 2012 Dec;14(12):1452-64. doi: 10.1093/neuonc/nos270. Epub 2012 Nov 6.

PMID:
23132408
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.

Ho PY, Chueh SC, Chiou SH, Wang SM, Lin WC, Lee IL, Yang HY, Peng HC, Lai MK.

Urol Oncol. 2013 Oct;31(7):1367-77. doi: 10.1016/j.urolonc.2012.01.015. Epub 2012 Mar 13.

PMID:
22417627
[PubMed - indexed for MEDLINE]
7.

Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.

Yuan J, Liu S, Yu Q, Lin Y, Bi Y, Wang Y, An R.

Acta Histochem. 2013 Jun;115(5):470-4. doi: 10.1016/j.acthis.2012.11.002. Epub 2012 Dec 12.

PMID:
23245688
[PubMed - indexed for MEDLINE]
8.

Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.

Su Y, Qiu Q, Zhang X, Jiang Z, Leng Q, Liu Z, Stass SA, Jiang F.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):327-37. doi: 10.1158/1055-9965.EPI-09-0865.

PMID:
20142235
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.

Alamgeer M, Ganju V, Szczepny A, Russell PA, Prodanovic Z, Kumar B, Wainer Z, Brown T, Schneider-Kolsky M, Conron M, Wright G, Watkins DN.

Thorax. 2013 Dec;68(12):1095-104. doi: 10.1136/thoraxjnl-2012-203021. Epub 2013 Jul 22.

PMID:
23878161
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.

Zerati M, Leite KR, Pontes-Junior J, Segre CC, Reis ST, Srougi M, Dall'Oglio MF.

Int Braz J Urol. 2013 Jul-Aug;39(4):484-92. doi: 10.1590/S1677-5538.IBJU.2013.04.05.

PMID:
24054396
[PubMed - indexed for MEDLINE]
Free Article
11.

Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion.

Ma JJ, Kong LM, Liao CG, Jiang X, Wang Y, Bao TY.

Med Oncol. 2012 Dec;29(5):3306-13. doi: 10.1007/s12032-012-0265-1. Epub 2012 Jun 13.

PMID:
22692967
[PubMed - indexed for MEDLINE]
12.

Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.

Khoury T, Ademuyiwa FO, Chandrasekhar R, Jabbour M, Deleo A, Ferrone S, Wang Y, Wang X.

Mod Pathol. 2012 Mar;25(3):388-97. doi: 10.1038/modpathol.2011.172. Epub 2011 Nov 11. Erratum in: Mod Pathol. 2012 Jun;25(6):917. Chandraseekhar, Rameela [corrected to Chandrasekhar, Rameela].

PMID:
22080062
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.

Li X, Wan L, Geng J, Wu CL, Bai X.

J Thorac Oncol. 2012 Aug;7(8):1235-45. doi: 10.1097/JTO.0b013e318257cc6d.

PMID:
22617249
[PubMed - indexed for MEDLINE]
14.

RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.

Cui ZW, Xia Y, Ye YW, Jiang ZM, Wang YD, Wu JT, Sun L, Zhao J, Fa PP, Sun XJ, Gui YT, Cai ZM.

Asian Pac J Cancer Prev. 2012;13(7):3403-8.

PMID:
22994768
[PubMed - indexed for MEDLINE]
Free Article
15.

Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinoma.

Wu S, Wang Y, Sun L, Zhang Z, Jiang Z, Qin Z, Han H, Liu Z, Li X, Tang A, Gui Y, Cai Z, Zhou F.

BMC Cancer. 2011 Sep 26;11:413. doi: 10.1186/1471-2407-11-413.

PMID:
21943117
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.

Xue YJ, Xiao RH, Long DZ, Zou XF, Wang XN, Zhang GX, Yuan YH, Wu GQ, Yang J, Wu YT, Xu H, Liu FL, Liu M.

J Transl Med. 2012 Sep 24;10:200. doi: 10.1186/1479-5876-10-200.

PMID:
23006512
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Expression analysis of aldehyde dehydrogenase 1A1 (ALDH1A1) in colon and rectal cancer in association with prognosis and response to chemotherapy.

Kahlert C, Gaitzsch E, Steinert G, Mogler C, Herpel E, Hoffmeister M, Jansen L, Benner A, Brenner H, Chang-Claude J, Rahbari N, Schmidt T, Klupp F, Grabe N, Lahrmann B, Koch M, Halama N, Büchler M, Weitz J.

Ann Surg Oncol. 2012 Dec;19(13):4193-201. doi: 10.1245/s10434-012-2518-9. Epub 2012 Aug 10.

PMID:
22878609
[PubMed - indexed for MEDLINE]
18.

Prognostic implication of TIM-3 in clear cell renal cell carcinoma.

Yuan J, Jiang B, Zhao H, Huang Q.

Neoplasma. 2014;61(1):35-40.

PMID:
24195506
[PubMed - indexed for MEDLINE]
19.

[The neutrophil gelatinase-associated lipocalin, or LCN 2, marker of aggressiveness in clear cell renal cell carcinoma].

Perrin C, Patard JJ, Jouan F, Collet N, Théoleyre S, Edeline J, Zerrouki S, Laguerre B, Bellaud-Roturaud MA, Rioux-Leclercq N, Vigneau C.

Prog Urol. 2011 Nov;21(12):851-8. doi: 10.1016/j.purol.2011.06.005. Epub 2011 Sep 3. French.

PMID:
22035911
[PubMed - indexed for MEDLINE]
20.

Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.

Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.

J Urol. 2008 Oct;180(4):1284-9. doi: 10.1016/j.juro.2008.06.036. Epub 2008 Aug 15.

PMID:
18707725
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk